Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
This study has been completed.
Study NCT00003600 Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999 Last Updated: August 19, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anemia
Breast Cancer
Drug/Agent Toxicity by Tissue/Organ
Leukemia
Lung Cancer
Lymphoma
Precancerous/Nonmalignant Condition
Small Intestine Cancer
Additional conditions recognized in this trial
Breast Neoplasms
Duodenal Neoplasms
Ileal Neoplasms
Intestinal Neoplasms
Jejunal Neoplasms
Lung Neoplasms
Lymphoma, Large-Cell, Immunoblastic
Lymphoma, Non-Hodgkin
Multiple Myeloma
Myeloproliferative Disorders
Neoplasms
Neoplasms, Plasma Cell
Precancerous Conditions
More general conditions related to this trial
Blood Protein Disorders
Bone Marrow Diseases
Breast Diseases
Cardiovascular Diseases
Digestive System Diseases
Digestive System Neoplasms
Duodenal Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Ileal Diseases
Immune System Diseases
Immunoproliferative Disorders
Intestinal Diseases
Jejunal Diseases
Lung Diseases
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Neoplasms by Site
Paraproteinemias
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Skin Diseases
Thoracic Neoplasms
Vascular Diseases
Interventions listed in this trial
epoetin alfa
quality-of-life assessment
More general drug interventions related to this trial
Hematinics
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
North Central Cancer Treatment Group
National Cancer Institute (NCI)
Back to top of Main Content
